Anyone Believe JL or AA?

Quote

Anonymous

Guest
These guys are trying the same crap on us that Wall Street is not buying anymore. And how about AA talking about what a great year we had in Biomedicines (and no one is going on an achievement trip) - REALLY!
Sounds like things are promising over in Diabetes and Oncology or is that BS as well!
 




















Anonymous said:
These guys are trying the same crap on us that Wall Street is not buying anymore. And how about AA talking about what a great year we had in Biomedicines (and no one is going on an achievement trip) - REALLY!
Sounds like things are promising over in Diabetes and Oncology or is that BS as well!
Click to expand...

Okay, quit your whining! I took an 11% payout, down to $14.6mil
 




















Eli Lilly & Co., one of the companies hardest hit by generic competition, had little success in 2013. Except for a poorly received diagnostic for Alzheimer’s disease, the company has not seen FDA’s green light for a new product since the 2009 approval of the blood thinner Effient.


Lilly’s recent streak of late-stage clinical failures continued in 2013: It withdrew two drugs from development—the anti*depressant edivoxetine and the lymphoma treatment enzastaurin. And its cancer drug ramucirumab failed in late-stage clinical trials for breast cancer
 




Anonymous said:
Eli Lilly & Co., one of the companies hardest hit by generic competition, had little success in 2013. Except for a poorly received diagnostic for Alzheimer’s disease, the company has not seen FDA’s green light for a new product since the 2009 approval of the blood thinner Effient.


Lilly’s recent streak of late-stage clinical failures continued in 2013: It withdrew two drugs from development—the anti*depressant edivoxetine and the lymphoma treatment enzastaurin. And its cancer drug ramucirumab failed in late-stage clinical trials for breast cancer
Click to expand...

All that is true but we are damn good at obscenely increasing prices of existing products and declaring victory out of what others would consider failure!
 




I truly believe things are better in Oncology but would agree that the negative comments about other divisions are accurate. Oncology has high margins compared to other products, making it more attractive to the leadership.
 




Anonymous said:
I truly believe things are better in Oncology but would agree that the negative comments about other divisions are accurate. Oncology has high margins compared to other products, making it more attractive to the leadership.
Click to expand...

I heard the prima donnas in the oncology division make 2 calls a day. Worthless!
 








Anonymous said:
Screw these clowns! Im going to ride this out as long as I can! Average 1-2 calls per day, then when my DM is w/me, I'll take his ass on a milk run.
Click to expand...

I believe in these guys they are the heart and soul of this company and they would never do anything to compromise integrity, quality or honesty.......more Kool Aid pls.
 












Top Bottom
Back
Quote